Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000120598 | SCV000192867 | likely benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514521 | SCV000609830 | likely benign | not provided | 2017-03-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514521 | SCV001909506 | benign | not provided | 2019-12-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28767323) |
Labcorp Genetics |
RCV002055328 | SCV002490788 | benign | Rubinstein-Taybi syndrome | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514521 | SCV004140998 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | CREBBP: BS1 |
ITMI | RCV000120598 | SCV000084756 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Diagnostic Laboratory, |
RCV000514521 | SCV001741576 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514521 | SCV001968415 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935145 | SCV004750516 | likely benign | CREBBP-related disorder | 2023-01-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |